Literature DB >> 29387980

Hyperpyrexia and high fever as a predictor for serious bacterial infection (SBI) in children-a systematic review.

Noa Rosenfeld-Yehoshua1,2, Shiri Barkan3,4, Ibrahim Abu-Kishk5,3, Meirav Booch6, Ruth Suhami7, Eran Kozer3,4.   

Abstract

It is not clear if children with high fever are at increased risk for serious bacterial infection (SBI). Our aim was to systematically review if children suffering from high fever are at high risk for SBI. Our data sources were Embase, Medline, and Pubmed; from their inception until the last week of March 2017. The study selection were of cohort and case control studies comparing the incidence of SBI in children with hyperpyrexia with children with fever of 41 °C or less, and children with a temperature higher than 40 °C, with children with fever of 40 °C or less. Two reviewers independently pooled studies for detailed review using a structured data-collection form. We calculated the odds ratio and 95% confidence intervals (CI) for SBI, assuming a random-effects model. A sub-group analysis was conducted. In our results, 11 studies met the inclusion criteria. Two studies showed that children with hyperpyrexia are at higher risk for SBI (OR 1.96 95% CI 1.3-1.97). An increased risk for SBI in children with high fever (OR 3.21 95% CI 1.67; 6.22). SBI in infants with temperature over 40 °C was higher compared to infants with lower degree of fever (OR 6.3 95% CI 4.44; 8.95). On older children, the risk for SBI was only slightly higher in children with fever above 40 °C. The limitation of the study is the small amount of studies and that the heterogeneity of the studies was very high.
CONCLUSION: Young infants with temperature higher than 400 °C are at increased risk for SBI. Risk of SBI in older children with temperature > 400C is minimal. What is known: • An association between high fever and increased risk for SBI was reported in young infants. • Based on only two studies from the 1970s and 1980s, hyperpyrexia is associated with increased risk for SBI. What is new: • Infants under the age of 3 months with fever > 40 °C were found to have increased risk for SBI. • Risk of SBI in older children with temperature > 40 °C is minimal.

Entities:  

Keywords:  High fever; High temperature; Hyperpyrexia; Infant; Meningitis; Pediatric; Pneumonia; Pyelonephritis; SBI; Serious bacterial infection (SBI); UTI

Mesh:

Year:  2018        PMID: 29387980     DOI: 10.1007/s00431-018-3098-x

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  47 in total

1.  Validation and development of a clinical prediction rule in clinically suspected community-acquired pneumonia.

Authors:  Manuel D Bilkis; Nelly Gorgal; Miriam Carbone; Mirta Vazquez; Paulo Albanese; María Cecilia Branda; Elías Alterman; Daniela Rodriguez; Liliana Orellana; Osvaldo Bello Pedrosa
Journal:  Pediatr Emerg Care       Date:  2010-06       Impact factor: 1.454

2.  Prospective evaluation of the risk of serious bacterial infection in children who present to the emergency department with hyperpyrexia (temperature of 106 degrees F or higher).

Authors:  Barbara W Trautner; A Chantal Caviness; Gary R Gerlacher; Gail Demmler; Charles G Macias
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

3.  Fever in the first eight weeks of life.

Authors:  K B Roberts; M S Borzy
Journal:  Johns Hopkins Med J       Date:  1977-07

4.  Bacteremia in febrile children seen in a "walk-in" pediatric clinic.

Authors:  J E McGowan; L Bratton; J O Klein; M Finland
Journal:  N Engl J Med       Date:  1973-06-21       Impact factor: 91.245

5.  Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever.

Authors:  M E Santolaya; A M Alvarez; A Becker; J Cofré; N Enríquez; M O'Ryan; E Payá; J Pilorget; C Salgado; J Tordecilla; M Varas; M Villarroel; T Viviani; M Zubieta
Journal:  J Clin Oncol       Date:  2001-07-15       Impact factor: 44.544

6.  Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.

Authors:  Roland A Ammann; Andreas Hirt; Annette Ridolfi Lüthy; Christoph Aebi
Journal:  Pediatr Infect Dis J       Date:  2004-01       Impact factor: 2.129

7.  Diagnostic markers of serious bacterial infections in febrile infants younger than 90 days old.

Authors:  Adi Nosrati; Amir Ben Tov; Shimon Reif
Journal:  Pediatr Int       Date:  2014-02       Impact factor: 1.524

8.  Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin.

Authors:  I Olaciregui; U Hernández; J A Muñoz; J I Emparanza; J J Landa
Journal:  Arch Dis Child       Date:  2009-01-21       Impact factor: 3.791

9.  Prevalence of bacteriuria in febrile children.

Authors:  H Bauchner; B Philipp; B Dashefsky; J O Klein
Journal:  Pediatr Infect Dis J       Date:  1987-03       Impact factor: 2.129

10.  The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.

Authors:  K G Lucas; A E Brown; D Armstrong; D Chapman; G Heller
Journal:  Cancer       Date:  1996-02-15       Impact factor: 6.860

View more
  3 in total

1.  Blood biomarkers in early bacterial infection and sepsis diagnostics in feverish young children.

Authors:  Algirdas Dagys; Goda Laucaitytė; Augusta Volkevičiūtė; Silvijus Abramavičius; Rimantas Kėvalas; Astra Vitkauskienė; Lina Jankauskaitė
Journal:  Int J Med Sci       Date:  2022-04-11       Impact factor: 3.642

2.  Pyrexia in a young infant - is height of fever associated with serious bacterial infection?

Authors:  Victoria Shi Rui Tan; Gene Yong-Kwang Ong; Khai Pin Lee; Sashikumar Ganapathy; Shu-Ling Chong
Journal:  BMC Pediatr       Date:  2022-04-08       Impact factor: 2.125

3.  Fever of unknown origin (FUO) in children: a single-centre experience from Beijing, China.

Authors:  Bing Hu; Tian-Ming Chen; Shu-Ping Liu; Hui-Li Hu; Ling-Yun Guo; He-Ying Chen; Shao-Ying Li; Gang Liu
Journal:  BMJ Open       Date:  2022-03-16       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.